Profiling post-translational modifications of histones in human monocyte-derived macrophages

Proteome Science

Volumn 13, Issue 1, 2015, Pages

  Olszowy, Pawel ^a,b   Donnelly, Maire Rose ^a   Lee, Chanho ^a   Ciborowski, Pawel ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Histones; Innate immunity; Macrophage; Mass spectrometry; Post translational modification; Proteomics

Indexed keywords

HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4;

AMINO ACID SEQUENCE; ARTICLE; CITRULLINATION; ELECTRON TRANSPORT; EPIGENETICS; HISTONE MODIFICATION; HISTONE UBIQUITINATION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MACROPHAGE; MASS SPECTROMETRY; POST TRANSLATIONAL MODIFICATION; PROTEIN METHYLATION;

EID: 84942368301     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/s12953-015-0080-7     Document Type: Article

References (51)

1. Hodges C, Crabtree GR. Dynamics of inherently bounded histone modification domains. Proc Natl Acad Sci U S A. 2012;109:13296-301.
2. Lanouette S, Mongeon V, Figeys D, Couture JF. The functional diversity of protein lysine methylation. Mol Syst Biol. 2014;10:724.
3. Moradian A, Kalli A, Sweredoski MJ, Hess S. The top-down, middle-down, and bottom-up mass spectrometry approaches for characterization of histone variants and their post-translational modifications. Proteomics. 2014;14:489-97.
4. Martin-Subero JI, Esteller M. Profiling epigenetic alterations in disease. Adv Exp Med Biol. 2011;711:162-77.
5. Han Y, Garcia BA. Combining genomic and proteomic approaches for epigenetics research. Epigenomics. 2013;5:439-52.
6. Marsh DJ, Shah JS, Cole AJ. Histones and their modifications in ovarian cancer - drivers of disease and therapeutic targets. Front Oncol. 2014;4:144.
7. Ciarlo E, Savva A, Roger T. Epigenetics in sepsis: targeting histone deacetylases. Int J Antimicrob Agents. 2013;42(Suppl):S8-12.
8. Watters SA, Mlcochova P, Gupta RK. Macrophages: the neglected barrier to eradication. Curr Opin Infect Dis. 2013;26:561-6.
9. Spyropoulou A, Piperi C, Adamopoulos C, Papavassiliou AG. Deregulated chromatin remodeling in the pathobiology of brain tumors. Neruomol Med. 2013;15:1-24.
10. Mills CD. M1 and M2 macrophages: oracles of health and disease. Crit Rev Immunol. 2012;32:463-88.
11. Nakata K, Yamamoto M, Inagawa H, Soma G. Effects of interactions between intestinal microbiota and intestinal macrophages on health. Anticancer Res. 2013;33:2849-53.
12. Ciborowski P, Gendelman HE. Human immunodeficiency virus-mononuclear phagocyte interactions: emerging avenues of biomarker discovery, modes of viral persistence and disease pathogenesis. Curr HIV Res. 2006;4:279-91.
13. Klechevsky E, Banchereau J. Human dendritic cells subsets as targets and vectors for therapy. Ann N Y Acad Sci. 2013;1284:24-30.
14. Michallet MC, Rota G, Maslowski K, Guarda G. Innate receptors for adaptive immunity. Curr Opin Microbiol. 2013;16(3):296-302.
15. Stamatas GN, Morello 3rd AP, Mays DA. Early inflammatory processes in the skin. Curr Mol Med. 2013;13(8):1250-69.
16. McCusker RH, Kelley KW. Immune-neural connections: how the immune system's response to infectious agents influences behavior. J Exp Biol. 2013;216:84-98.
17. Thorne JL, Ouboussad L, Lefevre PF. Heterochromatin protein 1 gamma and IkappaB kinase alpha interdependence during tumour necrosis factor gene transcription elongation in activated macrophages. Nucleic Acids Res. 2012;40:7676-89.
18. Falvo JV, Tsytsykova AV, Goldfeld AE. Transcriptional control of the TNF gene. Curr Dir Autoimmun. 2010;11:27-60.
19. Falvo JV, Jasenosky LD, Kruidenier L, Goldfeld AE. Epigenetic control of cytokine gene expression: regulation of the TNF/LT locus and T helper cell differentiation. Adv Immunol. 2013;118:37-128.
20. Rangel-Salazar R, Wickstrom-Lindholm M, Aguilar-Salinas CA, Alvarado-Caudillo Y, Dossing KB, Esteller M, et al. Human native lipoprotein-induced de novo DNA methylation is associated with repression of inflammatory genes in THP-1 macrophages. BMC Genomics. 2011;12:582.
21. Minami J, Takada K, Aoki K, Shimada Y, Okawa Y, Usui N, et al. Purification and characterization of C-terminal truncated forms of histone H2A in monocytic THP-1 cells. Int J Biochem Cell Biol. 2007;39:171-80.
22. Jeong JB, Hong SC, Jeong HJ, Koo JS. Anti-inflammatory effect of 2-methoxy-4-vinylphenol via the suppression of NF-kappaB and MAPK activation, and acetylation of histone H3. Arch Pharm Res. 2011;34:2109-16.
23. Garcia BA, Mollah S, Ueberheide BM, Busby SA, Muratore TL, Shabanowitz J, et al. Chemical derivatization of histones for facilitated analysis by mass spectrometry. Nat Protoc. 2007;2:933-8.
24. Olins DE, Olins AL. Chromatin history: our view from the bridge. Nat Rev Mol Cell Biol. 2003;4:809-14.
25. Lau PN, Cheung P. Elucidating combinatorial histone modifications and crosstalks by coupling histone-modifying enzyme with biotin ligase activity. Nucleic Acids Res. 2013;41:e49.
26. Lin S, Garcia BA. Examining histone posttranslational modification patterns by high-resolution mass spectrometry. Methods Enzymol. 2012;512:3-28.
27. Jufvas A, Stralfors P, Vener AV. Histone variants and their post-translational modifications in primary human fat cells. PLoS One. 2011;6:e15960.
28. Olszowy PP, Burns A, Ciborowski PS. Pressure-assisted sample preparation for proteomic analysis. Anal Biochem. 2013;438:67-72.
29. Sarg B, Faserl K, Kremser L, Halfinger B, Sebastiano R, Lindner HH. Comparing and combining CE-ESI-MS and nano-LC-ESI-MS for the characterization of post-translationally modified histones. Mol Cell Proteomics. 2013;12(9):2640-56.
30. Ryan CA, Annunziato AT. Separation of histone variants and post-translationally modified isoforms by triton/acetic acid/urea polyacrylamide gel electrophoresis. Curr Protoc Mol Biol. 2001;Chapter 21:Unit 21.2.
31. Kalli A, Sweredoski MJ, Hess S. Data-dependent middle-down nano-liquid chromatography-electron capture dissociation-tandem mass spectrometry: an application for the analysis of unfractionated histones. Anal Chem. 2013;85:3501-7.
32. Jung SY, Li Y, Wang Y, Chen Y, Zhao Y, Qin J. Complications in the assignment of 14 and 28Da mass shift detected by mass spectrometry as in vivo methylation from endogenous proteins. Anal Chem. 2008;80:1721-9.
33. Kim JM, Ogura A. Changes in allele-specific association of histone modifications at the imprinting control regions during mouse preimplantation development. Genesis. 2009;47:611-6.
34. Monk D, Arnaud P, Apostolidou S, Hills FA, Kelsey G, Stanier P, et al. Limited evolutionary conservation of imprinting in the human placenta. Proc Natl Acad Sci U S A. 2006;103:6623-8.
35. Xie Z, Dai J, Dai L, Tan M, Cheng Z, Wu Y, et al. Lysine succinylation and lysine malonylation in histones. Mol Cell Proteomics. 2012;11:100-7.
36. Xiong L, Darwanto A, Sharma S, Herring J, Hu S, Filippova M, et al. Mass spectrometric studies on epigenetic interaction networks in cell differentiation. J Biol Chem. 2011;286:13657-68.
37. Scherer WF, Syverton JT, Gey GO. Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J Exp Med. 1953;97:695-710.
38. Henry RA, Kuo YM, Andrews AJ. Differences in specificity and selectivity between CBP and p300 acetylation of histone H3 and H3/H4. Biochemistry. 2013;52:5746-59.
39. Schiltz RL, Mizzen CA, Vassilev A, Cook RG, Allis CD, Nakatani Y. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J Biol Chem. 1999;274:1189-92.
40. Borun TW, Pearson D, Paik WK. Studies of histone methylation during the HeLa S-3 cell cycle. J Biol Chem. 1972;247:4288-98.
41. Cass KA, Clark EB, Rubenstein PA. Is the onset of actin histidine methylation under development control in the chick embryo. Arch Biochem Biophys. 1983;225:731-9.
42. Osbahr AJ. Chromatographic isolation and identification of methylated derivatives obtained from modified fibrinogen. Biomaterials. 1980;1:183-8.
43. Barthelemy NR, Bednarczyk A, Schaeffer-Reiss C, Jullien D, Van Dorsselaer A, Cavusoglu N. Proteomic tools for the investigation of human hair structural proteins and evidence of weakness sites on hair keratin coil segments. Anal Biochem. 2012;421:43-55.
44. Webb KJ, Zurita-Lopez CI, Al-Hadid Q, Laganowsky A, Young BD, Lipson RS, et al. A novel 3-methylhistidine modification of yeast ribosomal protein Rpl3 is dependent upon the YIL110W methyltransferase. J Biol Chem. 2010;285:37598-606.
45. Cerny M, Skalak J, Cerna H, Brzobohaty B. Advances in purification and separation of posttranslationally modified proteins. J Proteomics. 2013;92:2-27.
46. Boffa LC, Gruss RJ, Allfrey VG. Aberrant and nonrandom methylation of chromosomal DNA-binding proteins of colonic epithelial cells by 1,2-dimethylhydrazine. Cancer Res. 1982;42:382-8.
47. Boffa LC, Bolognesi C. Methylating agents: their target amino acids in nuclear proteins. Carcinogenesis. 1985;6:1399-401.
48. Zhou W, Zhu P, Wang J, Pascual G, Ohgi KA, Lozach J, et al. Histone H2A monoubiquitination represses transcription by inhibiting RNA polymerase II transcriptional elongation. Mol Cell. 2008;29:69-80.
49. Nickel BE, Allis CD, Davie JR. Ubiquitinated histone H2B is preferentially located in transcriptionally active chromatin. Biochemistry. 1989;28:958-63.
50. Darwanto A, Curtis MP, Schrag M, Kirsch W, Liu P, Xu G, et al. A modified "cross-talk" between histone H2B Lys-120 ubiquitination and H3 Lys-79 methylation. J Biol Chem. 2010;285:21868-76.
51. Cuthbert GL, Daujat S, Snowden AW, Erdjument-Bromage H, Hagiwara T, Yamada M, et al. Histone deimination antagonizes arginine methylation. Cell. 2004;118:545-53.